Dr Yiqian Chen completed her PhD in the Centenary Institute of Cancer Medicine and Cell Biology at the University of Sydney. Dr Chen’s previous work largely centred around the biological functions and therapeutic potential of dipeptidyl peptidases. Her early scientific work helped to establish the safe application of their inhibitors as a therapy for type 2 diabetes and cancer. In late 2016, she started her postdoctoral training in the Ovarian Cancer Biomarkers laboratory at Hudson Institute of Medical Research. Her current work is involved in understanding the role of dipeptidyl peptidases in ovarian cancer. She is also working to establish the direct effects of the photosensitiser on ovarian cancer cells.